Short-Term Diet Restriction but Not Alternate Day Fasting Prevents Cisplatin-Induced Nephrotoxicity in Mice

dc.contributor.authorGunebakan, Evrin
dc.contributor.authorYalcin, Esra
dc.contributor.authorCikler Dulger, Esra
dc.contributor.authorYigitbasi, Ahmet
dc.contributor.authorAtes, Nilay
dc.contributor.authorCaglayan, Aysun
dc.contributor.authorKilic, Ertugrul
dc.date.accessioned2026-08-12T17:50:14Z
dc.date.issued2020
dc.departmentFırat Üniversitesi
dc.description.abstractCisplatin (CP) is one of the most preferred platinum-containing antineoplastic drugs. However, even in nontoxic plasma concentrations, it may cause kidney injury. To be able to increase its effective pharmacological dose, its side effects need to be regarded. Diet restriction (DR) has been demonstrated to improve cellular survival in a number of disorders. In this context, we investigated the role of DR in CP-induced nephrotoxicity (CPN). Besides alternate DR, animals were exposed to DR for 3 days prior or after CP treatment. Here, we observed that both 3 days of DR reverses the nephrotoxic effect of CP, which was associated with improved physiological outcomes, such as serum creatine, blood-urea nitrogen and urea. These treatments significantly increased phosphorylation of survival kinases PI3K/Akt and ERK-1/2 and decreased the level of stress kinase JNK were noted. In addition, the activation level of signal transduction mediator p38 MAPK phosphorylation was higher particularly in both three-day DR groups. Next, animals were fed with carbohydrate-, protein- or fat-enriched diets in the presence of CP. Results indicated that not only fasting but also dietary content itself may play a determinant role in the severity of CPN. Our data suggest that DR is a promising approach to reduce CPN by regulating metabolism and cell signaling pathways.
dc.description.sponsorshipTurkish Academy of Science (TUBA)
dc.description.sponsorshipThis research was funded by the Turkish Academy of Science (TUBA).
dc.identifier.doi10.3390/biomedicines8020023
dc.identifier.issn2227-9059
dc.identifier.issue2
dc.identifier.orcid0000-0002-9476-8488
dc.identifier.orcid0000-0002-1064-7989
dc.identifier.orcid0000-0001-9542-5244
dc.identifier.orcid0000-0001-6494-8923
dc.identifier.orcid0000-0002-0719-5862
dc.identifier.orcid0000-0002-2657-3515
dc.identifier.pmid32028692
dc.identifier.scopus2-s2.0-85080914050
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/biomedicines8020023
dc.identifier.urihttps://hdl.handle.net/11508/62137
dc.identifier.volume8
dc.identifier.wosWOS:000519109200016
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofBiomedicines
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectcisplatin
dc.subjectfasting
dc.subjectrenal protection
dc.subjectacute kidney injury
dc.subjectnephrotoxicity
dc.subjectMAPK pathway
dc.titleShort-Term Diet Restriction but Not Alternate Day Fasting Prevents Cisplatin-Induced Nephrotoxicity in Mice
dc.typeArticle

Dosyalar